Orchard Plans EU Submission For GSK-Originated MLD Gene Therapy
Orchard is aiming to get its second autologous gene therapy on the market next year, with a European filing for MLD and a BLA to follow.
Orchard is aiming to get its second autologous gene therapy on the market next year, with a European filing for MLD and a BLA to follow.